The novel therapy of tirzepatide peptide represents a significant advance in the management of type 2 diabetes. Unlike existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – leading to greater blood sugar management and possible weight loss. Researchers are investigating its long-term advantages and p… Read More